Predictive value of lung function below the normal range and respiratory symptoms for progression of chronic obstructive pulmonary disease

Albers, M.; Schermer, T.; Heijdra, Y.; Molema, J.; Akkermans, R.; van Weel, C.
March 2008
Thorax;Mar2008, Vol. 63 Issue 3, p201
Academic Journal
Background: Chronic obstructive pulmonary disease (COPD( is an insidiously starting disease. Early detection has high priority because of the possibility of early implementation of smoking cessation interventions. An evidence based model for case finding of COPD is not yet available. Objective: To describe the early development of COPD, and to assess the predictive value of early signs (respiratory symptoms, lung function below the normal range, reversibility). Design and methods: In a prospective study, based in general practice, formerly undiagnosed subjects In = 464) were assessed at baseline and at 5 years for respiratory symptoms and pulmonary function. Odds ratios for early signs were calculated (adjusted for age, gender, pack-years at baseline and smoking behaviour during follow-up), and defined as possible indicators of disease progression. Results: Over a 5 year period, the percentage of subjects with obstruction increased from 7.5% (n = 35) at baseline to 24.8% In = 1151 at 5 years. The presence of mild early signs and lung function below the normal range at baseline were related to an increased risk of developing mild to moderate COPD (GOLD I: OR 1.87(95% Cl 1.22 to 2.87); GOLD II: OR 2.08 (95% Cl 1.29 to 3.37) to 2.54 (95% Cl 1.25 to 5.19)) at 5 years. Conclusion: Lung function below the normal range and early respiratory signs predict the development and progression of COPD.


Related Articles

  • Assessing the Performance of Two Lung Age Equations on the Australian Population: Using Data From the Cross-Sectional BOLD-Australia Study. Ivey, Marsha A.; Johns, David P.; Stevenson, Christopher; Maguire, Graeme P.; Toelle, Brett G.; Marks, Guy B.; Abramson, Michael J.; Wood-Baker, Richard // Nicotine & Tobacco Research;Dec2014, Vol. 16 Issue 12, p1629 

    Introduction: Lung age, a simple concept for patients to grasp, is frequently used as an aid in smoking cessation programs. Lung age equations should be continuously updated and should be made relevant for target populations. We observed how new lung age equations developed for Australian...

  • Drugs 'can slow COPD'. Pedder, Cato // Pulse;5/24/2007, Vol. 67 Issue 20, p8 

    The article focuses on the significance of drug treatment in reducing the progression of Chronic obstructive pulmonary disease (COPD). It was found out that patients on a combination of sameterol and fluticasone propionate slower rate of decline of lung function than those on medication. This...

  • 2008 - Telling smokers their "lung age" promoted successful smoking cessation. Grossman, Ellie; Sherman, Scott // ACP Journal Club;7/15/2008, Vol. 149 Issue 1, p4 

    The article presents a study that was conducted by G. Parkes and colleagues on whether describing to patients how smoking has accelerated their age-related decline in lung function increase smoking cessation rates. Parkes and colleagues investigated personalized health assessment with normative...

  • 'Breathe Better' campaign garners attention for COPD. Baltazar, Amanda // Drug Store News;7/23/2007 Special Digital Report, Vol. 29 Issue 9, p20 

    The article reports that the U.S. National Heart, Lung and Blood Institute (NHLBI) launches a "Breath Better" campaign to increase awareness and encourages people with symptoms of chronic obstructive pulmonary disease to get a simple breathing test. These symptoms include shortness of breath,...

  • A Randomized Controlled Trial of a Literacy-Sensitive Self-Management Intervention for Chronic Obstructive Pulmonary Disease Patients. Kiser, Katie; Jonas, Daniel; Warner, Zachary; Scanlon, Kelli; Bryant Shilliday, Betsy; DeWalt, Darren // JGIM: Journal of General Internal Medicine;Feb2012, Vol. 27 Issue 2, p190 

    Background: Low literacy skills are common and associated with a variety of poor health outcomes. This may be particularly important in patients with chronic illnesses such as chronic obstructive pulmonary disease (COPD) that require appropriate inhaler technique to maintain quality of life and...

  • Rate of progression of CT-quantified emphysema in male current and ex-smokers: a follow-up study. Hoesein, Firdaus A. A. Mohamed; Zanen, Pieter; de Jong, Pim A.; Ginneken, Bram van; Boezen, H. Marike; Groen, Harry J. M.; Oudkerk, Mathijs; de Koning, Harry J.; Postma, Dirkje S.; Lammers, Jan-Willem J. // Respiratory Research;May2013, Vol. 14 Issue 5, p1 

    Background: Little is known about the factors associated with CT-quantified emphysema progression in heavy smokers. The objective of this study was to investigate the effect of length of smoking cessation and clinical / demographical factors on the rate of emphysema progression and FEV1-decline...

  • Newer equations better predict lung age in smokers: a retrospective analysis using a cohort of randomly selected participants. Newbury, Wendy; Lorimer, Michelle; Crockett, Alan // Primary Care Respiratory Journal;Mar2012, Vol. 21 Issue 1, p78 

    Aims: To produce new lung age equations using four previously published predictive equations for forced expiratory volume in 1 second and to compare them with lung age equations published in 1985 and 2010. Methods: Initial comparisons used phantom subjects of different ages and levels of lung...

  • Combination therapy slows progression of COPD.  // Pulse;8/27/2008, Vol. 68 Issue 28, p8 

    The article cites a study which found out that long-acting ß-agonists combined with an inhaled steroid slow the progression of lung disease in patients with chronic obstructive pulmonary disease (COPD) in Great Britain. It examined that patients treated with salmeterol and fluticasone had...

  • Spirometry Screening for COPD? Maybe Not. Pruitt, Bill // RT: The Journal for Respiratory Care Practitioners;Feb2009, Vol. 22 Issue 2, p26 

    The article focuses on the impact of spirometry screening on chronic obstructive pulmonary disease (COPD) patients. It states that the use of spirometry screening improves the smoking cessation rates of COPD. It also notes the findings of the study by the U.S. Preventive Services Task Force on...


Read the Article


Sign out of this library

Other Topics